Review article: applying pharmacokinetics to optimise dosing of anti‐TNF biologics in acute severe ulcerative colitis

E-ISSN： 1365-2036|41|11|1094-1103

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.11, 2015-06, pp. : 1094-1103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review article: immunogenicity of anti‐TNF biologics in IBD – the role of patient, product and prescriber factors

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 10, 2013-11 ,pp. : 1188-1197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: tofacitinib and biologics for moderate‐to‐severe ulcerative colitis—what is best in class?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 539-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 10, 2015-11 ,pp. : 1158-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: pharmacological aspects of anti‐TNF biosimilars in inflammatory bowel diseases

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 10, 2015-11 ,pp. : 1158-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cultured blood T‐cell responses predict anti‐TNF therapy response in patients with ulcerative colitis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1149-1161

John Wiley & Sons Inc

Access to resources Recommend Favorite